Cargando…
Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756569/ https://www.ncbi.nlm.nih.gov/pubmed/33546810 http://dx.doi.org/10.1016/j.vaccine.2021.01.015 |
| _version_ | 1784851649773174784 |
|---|---|
| author | Gurwitz, David |
| author_facet | Gurwitz, David |
| author_sort | Gurwitz, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9756569 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97565692022-12-16 Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries Gurwitz, David Vaccine Letter to the Editor Elsevier Ltd. 2021-02-12 2021-02-02 /pmc/articles/PMC9756569/ /pubmed/33546810 http://dx.doi.org/10.1016/j.vaccine.2021.01.015 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gurwitz, David Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title | Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title_full | Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title_fullStr | Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title_full_unstemmed | Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title_short | Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
| title_sort | ethical tradeoffs in sars-cov-2 vaccine development: assuring fair availability for low-income countries |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756569/ https://www.ncbi.nlm.nih.gov/pubmed/33546810 http://dx.doi.org/10.1016/j.vaccine.2021.01.015 |
| work_keys_str_mv | AT gurwitzdavid ethicaltradeoffsinsarscov2vaccinedevelopmentassuringfairavailabilityforlowincomecountries |